nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A11—Methotrexate—esophageal cancer	0.246	0.307	CbGbCtD
Cefazolin—ABCC4—Methotrexate—esophageal cancer	0.229	0.285	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—esophageal cancer	0.143	0.178	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—esophageal cancer	0.0996	0.124	CbGbCtD
Cefazolin—ALB—Methotrexate—esophageal cancer	0.0848	0.106	CbGbCtD
Cefazolin—Superinfection—Capecitabine—esophageal cancer	0.00565	0.0598	CcSEcCtD
Cefazolin—Phlebitis—Carboplatin—esophageal cancer	0.00499	0.0529	CcSEcCtD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00383	0.0369	CbGpPWpGaD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00341	0.0329	CbGpPWpGaD
Cefazolin—Prothrombin level increased—Capecitabine—esophageal cancer	0.00312	0.0331	CcSEcCtD
Cefazolin—Pruritus genital—Capecitabine—esophageal cancer	0.00307	0.0325	CcSEcCtD
Cefazolin—Nephropathy toxic—Cisplatin—esophageal cancer	0.00303	0.0321	CcSEcCtD
Cefazolin—ABCC4—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00276	0.0266	CbGpPWpGaD
Cefazolin—ALB—Recycling of bile acids and salts—SLC10A2—esophageal cancer	0.00262	0.0253	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—GSTO1—esophageal cancer	0.00237	0.0229	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00232	0.0223	CbGpPWpGaD
Cefazolin—Oral candidiasis—Capecitabine—esophageal cancer	0.00202	0.0214	CcSEcCtD
Cefazolin—Nephropathy—Methotrexate—esophageal cancer	0.002	0.0212	CcSEcCtD
Cefazolin—ABCC4—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.00187	0.0181	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—GSTT1—esophageal cancer	0.00184	0.0177	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—ADH7—esophageal cancer	0.00183	0.0177	CbGpPWpGaD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00181	0.0175	CbGpPWpGaD
Cefazolin—Pain—Carboplatin—esophageal cancer	0.00181	0.0191	CcSEcCtD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00167	0.0161	CbGpPWpGaD
Cefazolin—Body temperature increased—Carboplatin—esophageal cancer	0.00167	0.0177	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—ADH1B—esophageal cancer	0.00161	0.0155	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00161	0.0155	CbGpPWpGaD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00153	0.0147	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP26A1—esophageal cancer	0.00149	0.0144	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00147	0.0142	CbGpPWpGaD
Cefazolin—Phlebitis—Cisplatin—esophageal cancer	0.00146	0.0155	CcSEcCtD
Cefazolin—Liver disorder—Methotrexate—esophageal cancer	0.0014	0.0148	CcSEcCtD
Cefazolin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.0014	0.0148	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—GSTO1—esophageal cancer	0.00139	0.0134	CbGpPWpGaD
Cefazolin—ALB—Bile acid and bile salt metabolism—SLC10A2—esophageal cancer	0.00137	0.0132	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—GSTO1—esophageal cancer	0.00137	0.0132	CbGpPWpGaD
Cefazolin—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00135	0.0143	CcSEcCtD
Cefazolin—ABCC4—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.00131	0.0126	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—ALDH3A1—esophageal cancer	0.00131	0.0126	CbGpPWpGaD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00128	0.0123	CbGpPWpGaD
Cefazolin—Colitis—Capecitabine—esophageal cancer	0.00123	0.013	CcSEcCtD
Cefazolin—Candida infection—Capecitabine—esophageal cancer	0.00122	0.013	CcSEcCtD
Cefazolin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00118	0.0125	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—PFN1—esophageal cancer	0.00117	0.0113	CbGpPWpGaD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00117	0.0112	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—BLVRB—esophageal cancer	0.00116	0.0112	CbGpPWpGaD
Cefazolin—Mouth ulceration—Capecitabine—esophageal cancer	0.00116	0.0123	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00114	0.012	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—ALDH2—esophageal cancer	0.00113	0.0109	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—PFN1—esophageal cancer	0.00112	0.0108	CbGpPWpGaD
Cefazolin—Phlebitis—Capecitabine—esophageal cancer	0.00108	0.0114	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—GSTT1—esophageal cancer	0.00108	0.0104	CbGpPWpGaD
Cefazolin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00106	0.0113	CcSEcCtD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00106	0.0103	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP2A6—esophageal cancer	0.00106	0.0103	CbGpPWpGaD
Cefazolin—Pancytopenia—Cisplatin—esophageal cancer	0.00104	0.011	CcSEcCtD
Cefazolin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00103	0.0109	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—PTGS1—esophageal cancer	0.00101	0.00972	CbGpPWpGaD
Cefazolin—ABCC4—ABC-family proteins mediated transport—ABCB1—esophageal cancer	0.000994	0.00958	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—PRDX1—esophageal cancer	0.000989	0.00953	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000974	0.00938	CbGpPWpGaD
Cefazolin—Renal failure—Cisplatin—esophageal cancer	0.000956	0.0101	CcSEcCtD
Cefazolin—Vaginal inflammation—Methotrexate—esophageal cancer	0.000954	0.0101	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—CFL1—esophageal cancer	0.000952	0.00917	CbGpPWpGaD
Cefazolin—Stomatitis—Cisplatin—esophageal cancer	0.000948	0.01	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—CFL1—esophageal cancer	0.000907	0.00874	CbGpPWpGaD
Cefazolin—Vaginal infection—Methotrexate—esophageal cancer	0.000901	0.00954	CcSEcCtD
Cefazolin—Aplastic anaemia—Methotrexate—esophageal cancer	0.000896	0.00949	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—SLC39A6—esophageal cancer	0.000882	0.0085	CbGpPWpGaD
Cefazolin—Blood creatinine increased—Capecitabine—esophageal cancer	0.000872	0.00923	CcSEcCtD
Cefazolin—Mouth ulceration—Methotrexate—esophageal cancer	0.000863	0.00913	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—CYP1B1—esophageal cancer	0.000858	0.00827	CbGpPWpGaD
Cefazolin—Abdominal pain upper—Capecitabine—esophageal cancer	0.00085	0.009	CcSEcCtD
Cefazolin—TPMT—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000846	0.00815	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—ADH7—esophageal cancer	0.000841	0.00811	CbGpPWpGaD
Cefazolin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000838	0.00887	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000838	0.00887	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—CYP19A1—esophageal cancer	0.000807	0.00777	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000795	0.00767	CbGpPWpGaD
Cefazolin—Pancytopenia—Capecitabine—esophageal cancer	0.000764	0.00809	CcSEcCtD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00076	0.00732	CbGpPWpGaD
Cefazolin—Neutropenia—Capecitabine—esophageal cancer	0.000752	0.00796	CcSEcCtD
Cefazolin—Flatulence—Cisplatin—esophageal cancer	0.000749	0.00793	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—HSPA5—esophageal cancer	0.000731	0.00705	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.000722	0.00696	CbGpPWpGaD
Cefazolin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000711	0.00753	CcSEcCtD
Cefazolin—Renal failure—Capecitabine—esophageal cancer	0.000705	0.00746	CcSEcCtD
Cefazolin—Anaemia—Cisplatin—esophageal cancer	0.000702	0.00744	CcSEcCtD
Cefazolin—Stomatitis—Capecitabine—esophageal cancer	0.000699	0.0074	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	0.000697	0.00672	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000695	0.0067	CbGpPWpGaD
Cefazolin—Leukopenia—Cisplatin—esophageal cancer	0.00068	0.0072	CcSEcCtD
Cefazolin—ALB—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.000671	0.00647	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.000671	0.00647	CbGpPWpGaD
Cefazolin—Agranulocytosis—Capecitabine—esophageal cancer	0.000669	0.00708	CcSEcCtD
Cefazolin—Convulsion—Cisplatin—esophageal cancer	0.000659	0.00697	CcSEcCtD
Cefazolin—Haemoglobin—Capecitabine—esophageal cancer	0.000647	0.00685	CcSEcCtD
Cefazolin—Hepatitis—Capecitabine—esophageal cancer	0.000644	0.00682	CcSEcCtD
Cefazolin—Haemorrhage—Capecitabine—esophageal cancer	0.000644	0.00682	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000624	0.0066	CcSEcCtD
Cefazolin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00062	0.00657	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—ABCC2—esophageal cancer	0.000611	0.00589	CbGpPWpGaD
Cefazolin—Erythema multiforme—Capecitabine—esophageal cancer	0.000609	0.00644	CcSEcCtD
Cefazolin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000607	0.00643	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—SOX2—esophageal cancer	0.000594	0.00573	CbGpPWpGaD
Cefazolin—Eosinophilia—Methotrexate—esophageal cancer	0.000593	0.00628	CcSEcCtD
Cefazolin—Anorexia—Cisplatin—esophageal cancer	0.000591	0.00626	CcSEcCtD
Cefazolin—Hypotension—Cisplatin—esophageal cancer	0.00058	0.00614	CcSEcCtD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00058	0.00559	CbGpPWpGaD
Cefazolin—Pancytopenia—Methotrexate—esophageal cancer	0.000568	0.00602	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—NFE2L2—esophageal cancer	0.000568	0.00548	CbGpPWpGaD
Cefazolin—Neutropenia—Methotrexate—esophageal cancer	0.00056	0.00593	CcSEcCtD
Cefazolin—Flatulence—Capecitabine—esophageal cancer	0.000552	0.00585	CcSEcCtD
Cefazolin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CALR—esophageal cancer	0.000547	0.00528	CbGpPWpGaD
Cefazolin—Decreased appetite—Cisplatin—esophageal cancer	0.000539	0.00571	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—PFN1—esophageal cancer	0.000532	0.00512	CbGpPWpGaD
Cefazolin—Pain—Cisplatin—esophageal cancer	0.00053	0.00562	CcSEcCtD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00053	0.00511	CbGpPWpGaD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000529	0.0056	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—esophageal cancer	0.000525	0.00556	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000521	0.00502	CbGpPWpGaD
Cefazolin—Stomatitis—Methotrexate—esophageal cancer	0.00052	0.00551	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—CAPZA1—esophageal cancer	0.000519	0.00501	CbGpPWpGaD
Cefazolin—Anaemia—Capecitabine—esophageal cancer	0.000518	0.00548	CcSEcCtD
Cefazolin—Feeling abnormal—Cisplatin—esophageal cancer	0.000511	0.00541	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—esophageal cancer	0.000506	0.00488	CbGpPWpGaD
Cefazolin—Syncope—Capecitabine—esophageal cancer	0.000502	0.00532	CcSEcCtD
Cefazolin—Leukopenia—Capecitabine—esophageal cancer	0.000501	0.00531	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—esophageal cancer	0.000498	0.00527	CcSEcCtD
Cefazolin—Loss of consciousness—Capecitabine—esophageal cancer	0.000492	0.00521	CcSEcCtD
Cefazolin—Body temperature increased—Cisplatin—esophageal cancer	0.00049	0.00519	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—CYP2A6—esophageal cancer	0.000489	0.00471	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000484	0.00466	CbGpPWpGaD
Cefazolin—Haemoglobin—Methotrexate—esophageal cancer	0.000482	0.0051	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—esophageal cancer	0.000479	0.00507	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—esophageal cancer	0.000479	0.00507	CcSEcCtD
Cefazolin—Confusional state—Capecitabine—esophageal cancer	0.000461	0.00488	CcSEcCtD
Cefazolin—Hypersensitivity—Cisplatin—esophageal cancer	0.000457	0.00484	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—esophageal cancer	0.000453	0.0048	CcSEcCtD
Cefazolin—Shock—Capecitabine—esophageal cancer	0.00045	0.00476	CcSEcCtD
Cefazolin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000448	0.00474	CcSEcCtD
Cefazolin—Asthenia—Cisplatin—esophageal cancer	0.000445	0.00471	CcSEcCtD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000442	0.00426	CbGpPWpGaD
Cefazolin—Anorexia—Capecitabine—esophageal cancer	0.000436	0.00462	CcSEcCtD
Cefazolin—TPMT—Metabolism—SLC52A3—esophageal cancer	0.000433	0.00418	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—BLVRB—esophageal cancer	0.000433	0.00418	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000433	0.00418	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—CFL1—esophageal cancer	0.000431	0.00415	CbGpPWpGaD
Cefazolin—Hypotension—Capecitabine—esophageal cancer	0.000427	0.00452	CcSEcCtD
Cefazolin—Diarrhoea—Cisplatin—esophageal cancer	0.000424	0.00449	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000422	0.00407	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—CFL1—esophageal cancer	0.00041	0.00395	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000407	0.00393	CbGpPWpGaD
Cefazolin—Dyspepsia—Capecitabine—esophageal cancer	0.000402	0.00426	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000398	0.00384	CbGpPWpGaD
Cefazolin—Decreased appetite—Capecitabine—esophageal cancer	0.000397	0.00421	CcSEcCtD
Cefazolin—Vomiting—Cisplatin—esophageal cancer	0.000394	0.00418	CcSEcCtD
Cefazolin—Fatigue—Capecitabine—esophageal cancer	0.000394	0.00417	CcSEcCtD
Cefazolin—Rash—Cisplatin—esophageal cancer	0.000391	0.00414	CcSEcCtD
Cefazolin—Pain—Capecitabine—esophageal cancer	0.000391	0.00414	CcSEcCtD
Cefazolin—Dermatitis—Cisplatin—esophageal cancer	0.000391	0.00414	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000386	0.00372	CbGpPWpGaD
Cefazolin—Anaemia—Methotrexate—esophageal cancer	0.000385	0.00408	CcSEcCtD
Cefazolin—Feeling abnormal—Capecitabine—esophageal cancer	0.000377	0.00399	CcSEcCtD
Cefazolin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000374	0.00396	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—esophageal cancer	0.000373	0.00395	CcSEcCtD
Cefazolin—TPMT—Metabolism—CA1—esophageal cancer	0.000369	0.00355	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC10A2—esophageal cancer	0.000369	0.00355	CbGpPWpGaD
Cefazolin—Nausea—Cisplatin—esophageal cancer	0.000368	0.0039	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000368	0.00355	CbGpPWpGaD
Cefazolin—Urticaria—Capecitabine—esophageal cancer	0.000363	0.00385	CcSEcCtD
Cefazolin—Abdominal pain—Capecitabine—esophageal cancer	0.000361	0.00383	CcSEcCtD
Cefazolin—Body temperature increased—Capecitabine—esophageal cancer	0.000361	0.00383	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—esophageal cancer	0.000361	0.00383	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000353	0.0034	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000353	0.0034	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000347	0.00335	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ATP1B2—esophageal cancer	0.000344	0.00332	CbGpPWpGaD
Cefazolin—Confusional state—Methotrexate—esophageal cancer	0.000343	0.00363	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—TGFBR2—esophageal cancer	0.000343	0.0033	CbGpPWpGaD
Cefazolin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00034	0.0036	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—SMAD4—esophageal cancer	0.000339	0.00327	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HMOX1—esophageal cancer	0.000338	0.00326	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CA2—esophageal cancer	0.000337	0.00325	CbGpPWpGaD
Cefazolin—Hypersensitivity—Capecitabine—esophageal cancer	0.000337	0.00357	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000333	0.00353	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD2—esophageal cancer	0.000332	0.0032	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—HSPA5—esophageal cancer	0.000331	0.00319	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00033	0.00318	CbGpPWpGaD
Cefazolin—Asthenia—Capecitabine—esophageal cancer	0.000328	0.00347	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—esophageal cancer	0.000324	0.00344	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000324	0.00313	CbGpPWpGaD
Cefazolin—Pruritus—Capecitabine—esophageal cancer	0.000323	0.00343	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—esophageal cancer	0.000318	0.00337	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000317	0.00305	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	0.000315	0.00304	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000314	0.00303	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ADH7—esophageal cancer	0.000313	0.00302	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PLCE1—esophageal cancer	0.000313	0.00302	CbGpPWpGaD
Cefazolin—Diarrhoea—Capecitabine—esophageal cancer	0.000313	0.00331	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—DOCK2—esophageal cancer	0.000311	0.003	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000311	0.00299	CbGpPWpGaD
Cefazolin—Somnolence—Methotrexate—esophageal cancer	0.000303	0.0032	CcSEcCtD
Cefazolin—Dizziness—Capecitabine—esophageal cancer	0.000302	0.0032	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—esophageal cancer	0.0003	0.00317	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000298	0.00287	CbGpPWpGaD
Cefazolin—Decreased appetite—Methotrexate—esophageal cancer	0.000296	0.00313	CcSEcCtD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000295	0.00284	CbGpPWpGaD
Cefazolin—Fatigue—Methotrexate—esophageal cancer	0.000293	0.00311	CcSEcCtD
Cefazolin—Pain—Methotrexate—esophageal cancer	0.000291	0.00308	CcSEcCtD
Cefazolin—Vomiting—Capecitabine—esophageal cancer	0.000291	0.00308	CcSEcCtD
Cefazolin—Rash—Capecitabine—esophageal cancer	0.000288	0.00305	CcSEcCtD
Cefazolin—Dermatitis—Capecitabine—esophageal cancer	0.000288	0.00305	CcSEcCtD
Cefazolin—Headache—Capecitabine—esophageal cancer	0.000286	0.00303	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000282	0.00272	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000281	0.00271	CbGpPWpGaD
Cefazolin—Feeling abnormal—Methotrexate—esophageal cancer	0.00028	0.00297	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000278	0.00295	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000276	0.00266	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ADH1B—esophageal cancer	0.000275	0.00265	CbGpPWpGaD
Cefazolin—Nausea—Capecitabine—esophageal cancer	0.000272	0.00288	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—esophageal cancer	0.00027	0.00286	CcSEcCtD
Cefazolin—ALB—Folate Metabolism—SOD2—esophageal cancer	0.00027	0.0026	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000269	0.0026	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000269	0.0026	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000269	0.0026	CbGpPWpGaD
Cefazolin—Body temperature increased—Methotrexate—esophageal cancer	0.000269	0.00285	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—esophageal cancer	0.000269	0.00285	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—PFN1—esophageal cancer	0.000269	0.00259	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000268	0.00258	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TYMP—esophageal cancer	0.000263	0.00253	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000259	0.0025	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000258	0.00249	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000258	0.00249	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP26A1—esophageal cancer	0.000255	0.00246	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000251	0.00242	CbGpPWpGaD
Cefazolin—Hypersensitivity—Methotrexate—esophageal cancer	0.000251	0.00266	CcSEcCtD
Cefazolin—TPMT—Metabolism—ALOX15—esophageal cancer	0.000249	0.0024	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000246	0.00237	CbGpPWpGaD
Cefazolin—Asthenia—Methotrexate—esophageal cancer	0.000244	0.00259	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000243	0.00234	CbGpPWpGaD
Cefazolin—Pruritus—Methotrexate—esophageal cancer	0.000241	0.00255	CcSEcCtD
Cefazolin—TPMT—Metabolism—TPI1—esophageal cancer	0.000237	0.00229	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTO1—esophageal cancer	0.000237	0.00229	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000236	0.00227	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAPZA1—esophageal cancer	0.000235	0.00227	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000234	0.00226	CbGpPWpGaD
Cefazolin—Diarrhoea—Methotrexate—esophageal cancer	0.000233	0.00247	CcSEcCtD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00023	0.00222	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDOB—esophageal cancer	0.000228	0.00219	CbGpPWpGaD
Cefazolin—Dizziness—Methotrexate—esophageal cancer	0.000225	0.00238	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000225	0.00217	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000225	0.00217	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GAPDH—esophageal cancer	0.000219	0.00211	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CFL1—esophageal cancer	0.000218	0.0021	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CRABP1—esophageal cancer	0.000217	0.00209	CbGpPWpGaD
Cefazolin—Vomiting—Methotrexate—esophageal cancer	0.000216	0.00229	CcSEcCtD
Cefazolin—Rash—Methotrexate—esophageal cancer	0.000215	0.00227	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—esophageal cancer	0.000214	0.00227	CcSEcCtD
Cefazolin—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000214	0.00207	CbGpPWpGaD
Cefazolin—Headache—Methotrexate—esophageal cancer	0.000213	0.00226	CcSEcCtD
Cefazolin—TPMT—Metabolism—GNG7—esophageal cancer	0.000207	0.00199	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GNG7—esophageal cancer	0.000205	0.00198	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000204	0.00197	CbGpPWpGaD
Cefazolin—Nausea—Methotrexate—esophageal cancer	0.000202	0.00214	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000196	0.00189	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDH2—esophageal cancer	0.000194	0.00187	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000191	0.00184	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000185	0.00179	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTT1—esophageal cancer	0.000184	0.00177	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2A6—esophageal cancer	0.000182	0.00175	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.00018	0.00174	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000178	0.00171	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS1—esophageal cancer	0.000173	0.00166	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ENO1—esophageal cancer	0.000173	0.00166	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00017	0.00164	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSME2—esophageal cancer	0.00017	0.00164	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSME1—esophageal cancer	0.00017	0.00164	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HSPA5—esophageal cancer	0.000167	0.00161	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ATP1B2—esophageal cancer	0.000156	0.0015	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000155	0.00149	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000151	0.00145	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000148	0.00143	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000147	0.00141	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1B1—esophageal cancer	0.000147	0.00141	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000143	0.00138	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000142	0.00137	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—DOCK2—esophageal cancer	0.000141	0.00136	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP19A1—esophageal cancer	0.000138	0.00133	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000135	0.0013	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—esophageal cancer	0.000135	0.0013	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000128	0.00123	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMOX1—esophageal cancer	0.000126	0.00121	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ABL1—esophageal cancer	0.000124	0.00119	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000122	0.00117	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PFN1—esophageal cancer	0.000122	0.00117	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ABCB1—esophageal cancer	0.000121	0.00116	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.00012	0.00116	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000117	0.00113	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000117	0.00113	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000113	0.00109	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000108	0.00104	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000108	0.00104	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000104	0.001	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000102	0.000981	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CFL1—esophageal cancer	9.85e-05	0.000949	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.49e-05	0.000915	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.42e-05	0.000908	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNG7—esophageal cancer	9.28e-05	0.000895	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.04e-05	0.000871	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—esophageal cancer	9.02e-05	0.000869	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS2—esophageal cancer	8.93e-05	0.000861	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.89e-05	0.000856	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.86e-05	0.000854	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CREBBP—esophageal cancer	8.07e-05	0.000778	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.04e-05	0.000774	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CREBBP—esophageal cancer	8.02e-05	0.000773	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BLVRB—esophageal cancer	7.9e-05	0.000761	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC52A3—esophageal cancer	7.9e-05	0.000761	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	7.84e-05	0.000755	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HSPA5—esophageal cancer	7.57e-05	0.000729	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.24e-05	0.000698	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—esophageal cancer	7.23e-05	0.000697	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—esophageal cancer	7.18e-05	0.000692	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.06e-05	0.00068	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.94e-05	0.000669	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA1—esophageal cancer	6.71e-05	0.000647	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC10A2—esophageal cancer	6.71e-05	0.000647	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—esophageal cancer	6.61e-05	0.000637	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA2—esophageal cancer	6.14e-05	0.000592	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.04e-05	0.000582	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6e-05	0.000578	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADH7—esophageal cancer	5.71e-05	0.00055	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLCE1—esophageal cancer	5.71e-05	0.00055	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.64e-05	0.000544	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ABL1—esophageal cancer	5.61e-05	0.00054	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—EP300—esophageal cancer	5.5e-05	0.00053	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EP300—esophageal cancer	5.46e-05	0.000526	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADH1B—esophageal cancer	5.01e-05	0.000482	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.9e-05	0.000472	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMP—esophageal cancer	4.78e-05	0.000461	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.7e-05	0.000453	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP26A1—esophageal cancer	4.65e-05	0.000449	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALOX15—esophageal cancer	4.54e-05	0.000437	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTO1—esophageal cancer	4.33e-05	0.000417	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TPI1—esophageal cancer	4.33e-05	0.000417	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOB—esophageal cancer	4.15e-05	0.0004	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—esophageal cancer	4.07e-05	0.000392	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS2—esophageal cancer	4.04e-05	0.000389	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—esophageal cancer	4.04e-05	0.000389	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GAPDH—esophageal cancer	3.99e-05	0.000385	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CRABP1—esophageal cancer	3.96e-05	0.000381	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—esophageal cancer	3.91e-05	0.000377	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNG7—esophageal cancer	3.76e-05	0.000363	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CREBBP—esophageal cancer	3.63e-05	0.00035	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	3.55e-05	0.000342	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH2—esophageal cancer	3.53e-05	0.00034	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—esophageal cancer	3.35e-05	0.000323	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2A6—esophageal cancer	3.32e-05	0.00032	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.3e-05	0.000318	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—esophageal cancer	3.25e-05	0.000313	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO1—esophageal cancer	3.14e-05	0.000303	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS1—esophageal cancer	3.14e-05	0.000303	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.14e-05	0.000303	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSME1—esophageal cancer	3.1e-05	0.000299	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSME2—esophageal cancer	3.1e-05	0.000299	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.7e-05	0.000261	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1B1—esophageal cancer	2.67e-05	0.000258	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—esophageal cancer	2.51e-05	0.000242	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EP300—esophageal cancer	2.47e-05	0.000238	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—esophageal cancer	2.29e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.25e-05	0.000217	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—esophageal cancer	2.2e-05	0.000212	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—esophageal cancer	1.83e-05	0.000176	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—esophageal cancer	1.77e-05	0.00017	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.66e-05	0.00016	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CREBBP—esophageal cancer	1.47e-05	0.000142	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—esophageal cancer	1.32e-05	0.000127	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.000116	CbGpPWpGaD
Cefazolin—ALB—Metabolism—EP300—esophageal cancer	1e-05	9.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—esophageal cancer	7.41e-06	7.14e-05	CbGpPWpGaD
